| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5741510 | TEIKOKU PHARMA USA | Adhesive patch for applying analgesic medication to the skin |
Mar, 2014
(10 years ago) | |
| US5827529 | TEIKOKU PHARMA USA | External preparation for application to the skin containing lidocaine |
Oct, 2015
(8 years ago) | |
Lidoderm is owned by Teikoku Pharma Usa.
Lidoderm contains Lidocaine.
Lidoderm has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Lidoderm are:
- US5741510
- US5827529
Lidoderm was authorised for market use on 19 March, 1999.
Lidoderm is available in patch;topical dosage forms.
Lidoderm can be used as external preparation for application to the skin containing lidocaine-drug retaining layer placed on support and comprises adhesive gel base 1-10% by weight of lidocaine.
The generics of Lidoderm are possible to be released after 27 October, 2015.
Drugs and Companies using LIDOCAINE ingredient
Market Authorisation Date: 19 March, 1999
Treatment: External preparation for application to the skin containing lidocaine-drug retaining layer placed on support and comprises adhesive gel base 1-10% by weight of lidocaine
Dosage: PATCH;TOPICAL
LIDODERM family patents
